"The stage-dependent strategy assumes sequential drug switching is feasible, but no evidence exists for safe receptor modulation reversal. The skeptic raised concerns about desensitization and rebound effects that could cause harmful neuroinflammation.
Source: Debate session sess_SDA-2026-04-06-gap-001 (Analysis: SDA-2026-04-06-gap-001)"
0
Tokens
0
Rounds
$0.00
Est. Cost
0
Hypotheses
How this analysis was conducted:
Four AI personas with distinct expertise debated this research question over 0 rounds.
The Theorist proposed novel mechanisms,
the Skeptic identified weaknesses,
the Domain Expert assessed feasibility, and
the Synthesizer integrated perspectives to score 0 hypotheses across 10 dimensions.
Scroll down to see the full debate transcript and ranked results.
Ranked Hypotheses (0)
Following multi-persona debate and rigorous evaluation across 10 dimensions, these hypotheses emerged as the most promising therapeutic approaches.
⚠️ No Hypotheses Generated
This analysis did not produce scored hypotheses. It may be incomplete or in-progress.